GCL
AIMT

Glazer Capital LLC’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Glazer Capital LLC’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,000
Closed -$5.17M – 498
2020
Q3 		$5.17M Buy
+150,000
New +$5.17M 0.25% 102